Effects of Iranian herbal Zofa® syrup for the management of clinical symptoms in patients with COVID-19: A randomized clinical trial | ||
| Avicenna Journal of Phytomedicine | ||
| دوره 13، شماره 5، آذر و دی 2023، صفحه 500-512 اصل مقاله (669.9 K) | ||
| نوع مقاله: Original Research Article | ||
| شناسه دیجیتال (DOI): 10.22038/ajp.2023.21909 | ||
| نویسندگان | ||
| Ali Ghazvini1؛ Amir Vahedian-azimi2؛ Morteza Abdoli1؛ Farshid Rahimibashar3؛ Yunes Panahi4؛ Thozhukat Sathyapalan5؛ Amirhossein Sahebkar* 6 | ||
| 1Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran | ||
| 2Trauma Research Center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran | ||
| 3Department of Anesthesiology and Critical Care, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran | ||
| 4Pharmacotherapy Department, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran | ||
| 5Academic Diabetes, Endocrinology and Metabolism, Allam Diabetes Centre Hull Royal Infirmary Anlaby Road HU3 2JZ, Hull, UK | ||
| 6Applied Biomedical Research Center, Mashhad University of Medical Sciences, Tehran, Iran. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Tehran, Iran | ||
| چکیده | ||
| Objective: The objective of this study was to determine the role of Iranian herbal Zofa® syrup in improving the clinical symptoms of patients with COVID-19. Materials and Methods: This randomized clinical trial was conducted on 105 patients with COVID-19. Patients were randomly assigned to the intervention (n=35) group (received 10 ml of Zofa® syrup every 8 hours/seven days plus standard treatment) or the control (n=70) group (received only standard treatment). Assessments were performed before and after treatment. Results: The groups were comparable regarding age (p=0.980), gender (p=0.584), comorbidities (p=0.318), or drug history (p=0.771). There was no difference between patients' recovery status at the time of discharge (p=0.327) or two weeks post-discharge (p=0.165) in the intervention and control groups. No patient was hospitalized to the intensive care unit (ICU) for supplemental oxygen therapy and no patient died in the intervention group. However, in the control group, three (4.5%) patients were transferred to the ICU, and two (3.03%) patients died. Conclusion: Considering the better recovery status of the patients at the time of discharge and the absence of patient deaths in the intervention group, more additional studies are needed to confirm these findings and elucidate the role of Zofa® in COVID-19. | ||
| کلیدواژهها | ||
| Coronavirus disease 2019؛ Herbal medicine؛ Respiratory infection؛ Symptoms؛ Iran | ||
| مراجع | ||
|
Ahmadi R, Salari S, Sharifi MD, Reihani H, Rostamiani MB, Behmadi M, Taherzadeh Z, Eslami S, Rezayat SM, Jaafari MR, Elyasi S. 2021. Oral nano-curcumin formulation efficacy in the management of mild to moderate outpatient COVID-19: a randomized triple-blind placebo-controlled clinical trial. Food Sci Nutr, 9: 4068-4075. Babich O, Sukhikh S, Prosekov A, Asyakina L, Ivanova S. 2020. Medicinal plants to strengthen immunity during a pandemic. Pharmaceuticals (Basel), 13: 12-18. Banaee M, Soleimany V, Nematdoost Haghi B. 2017. Therapeutic effects of marshmallow (Althaea officinalis L.) extract on plasma biochemical parameters of common carp infected with Aeromonas hydrophila. Vet Res Forum, 8: 145-153. Bhattacharyya R, Iyer P, Phua GC, Lee JH. 2020. The interplay between coagulation and inflammation pathways in COVID-19- associated respiratory failure: a narrative review. Pulm Ther, 6: 215-231. Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. 2020. Pathophysiology of COVID-19: mechanisms underlying disease severity and progression. Physiology. Physiology (Bethesda), 35: 288-301. Bonaterra GA, Bronischewski K, Hunold, P, Schwarzbach H, Heinrich EU, Fink C, Aziz-Kalbhenn H, Müller J, Kinscherf R. 2020. Anti-inflammatory and anti-oxidative effects of phytohustil(®) and root extract of althaea officinalis L. on macrophages in vitro. Front Pharmacol, 11: 290-295. Borrelli F, Pagano E, Formisano C, Piccolella S, Fiorentino A, Tenore, GC, Izzo AA, Rigano D, Pacifico S. 2019. Hyssopus officinalis subsp. aristatus: An unexploited wild-growing crop for new disclosed bioactives. Ind Crops Prod, 140: 11-15. Champasuri S, Itharat A. 2016. Bioactivities of ethanolic extracts of three parts (wood, nutmeg and mace) from myristica fragrans houtt. J Med Assoc Thai, 99 Suppl 4: S124- S130. Choopani R, Sadr S, Kaveh S, Kaveh, N, Dehghan S. 2015. Pharmacological treatment of catarrh in Iranian traditional medicine. J Tradit Complement Med, 5: 71- 74. Costela-Ruiz VJ, Illescas-Montes R, PuertaPuerta JM, Ruiz C, Melguizo-Rodríguez L. 2020. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev, 54: 62-75. Cuschieri S. 2019. The CONSORT statement. Saudi J Anaesth, 13: S27-S30. Effects of Zofa® syrup on COVID-19 AJP, Vol. 13, No. 5, Sep-Oct 2023 511 Fiore C, Eisenhut M, Krausse R, Ragazzi, E, Pellati D, Armanini, D, Bielenberg J. 2008. Antiviral effects of Glycyrrhiza species. Phytother Res, 22: 141-148. Hansell DM, Bankier AA, Macmahon H, Mcloud TC, Muller NL, Remy J. 2008. Fleischner Society: glossary of terms for thoracic imaging. Radiology, 246: 697-722. Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut, A, Peacock SJ, Robertson DL, Consortium CGU. 2021. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol, 19: 409-424. Helsinki. 2013. Ethical principles for medical research involving human subjects. JAMA, 310: 2191-2194. Hosseini SA, Zahedipour F, Sathyapalan T, Jamialahmadi T, Sahebkar A. 2021. Pulmonary fibrosis: therapeutic and mechanistic insights into the role of phytochemicals. BioFactors, 47: 250-269. Iranzadasl M, Karimi Y, Moadeli F, Pasalar M. 2021. Persian medicine recommendations for the prevention of pandemics related to the respiratory system: a narrative literature review. Integr Med Res, 10: 10048-10053. Irwin RS, Dudiki N, French CL. 2020. Lifethreatening and non-life-threatening complications associated with coughing: a scoping review. Chest, 158: 2058-2073. Jacobs SS. 2020. Complications of chronic cough: another call for treatment strategies. Chest, 158: 1818-1819. Karsch-Völk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K, Linde K. 2014. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev, 2: 530-532. Letessier MP, Svoboda KP, Walters DR. 2001. Antifungal activity of the essential oil of hyssop (Hyssopus officinalis). J Phytopathol, 149: 673-678. Martins CF, Campos ML, Irioda AC, Stremel DP, Trindade A, Pontarolo R. 2017. Antiinflammatory effect of malva sylvestris, sida cordifolia, and pelargonium graveolens is related to inhibition of prostanoid production. Molecules, 22: 14-16. Mesaik AM, Poh HW, Bin OY, Elawad I, Alsayed B. 2018. In vivo antiInflammatory, anti-bacterial and antidiarrhoeal activity of ziziphus jujuba fruit extract. Open Access Maced J Med Sci, 6: 757-766. Monavari H, Hamkar R, Babaei NZ, Adibi, L, Noroozi M, Ziaei A. 2007. Antiviral effect assay of twenty five species of various medicinal plants families in Iran. IJM, 1: 49-59. Otto SP, Day T, Arino J, Colijn C, Dushoff J, Li M, Mechai S, Van-Domselaar G, Wu J, Earn-D JD, Ogden NH. 2021. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Current Biology, 31: R918-R929. Pandey V, Verma RS, Chauhan A, Tiwari R. 2014. Compositional variation in the leaf, flower and stem essential oils of Hyssop (Hyssopus officinalis L.) from WesternHimalaya. J Herb Med, 4: 89-95. Paudyal V, Sun S, Hussain R, Abutaleb MH, Hedima EW. 2022. Complementary and alternative medicines use in COVID-19: a global perspective on practice, policy and research. Res Social Adm Pharm, 18: 2524- 2528. Pawar KS, Mastud RN, Pawar SK, Pawar, SS, Bhoite RR, Bhoite RR, Kulkarni MV, Deshpande AR. 2021. Oral curcumin with piperine as adjuvant therapy for the treatment of COVID-19: a randomized clinical trial. Front Pharmacol, 12: 6693- 6696. Perotin JM, Launois C, Dewolf M, Dumazet A, Dury S, Lebargy F, Dormoy V, Deslee G. 2018. Managing patients with chronic cough: challenges and solutions. Ther Clin Risk Manag, 14: 1041-1051. Proal AD, Vanelzakker MB. 2021. Long COVID or post-acute sequelae of COVID19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol, 12: 6981- 6985. Rahmanzade R, Rahmanzadeh R, Hashemian SM, Tabarsi P. 2020. Iran's approach to COVID-19: evolving treatment protocols and ongoing clinical trials. Front Public Health, 8: 5518-5519. Rajaei A, Salarbashi D, Asrari N, Fazly Bazzaz BS, Aboutorabzade, SM, Shaddel R. 2021. Antioxidant, antimicrobial, and cytotoxic activities of extracts from the seed and pulp of Jujube (Ziziphus jujuba) grown in Iran. Food Sci Nutr, 9: 682-691. Ghazvini et al. AJP, Vol. 13, No. 5, Sep-Oct 2023 512 Schoen K, Horvat N, Guerreiro NFC, De Castro I, De Giassi KS. 2019. Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC Infect Dis, 19: 964-968. Sokmen A, Gulluce M, Askin Akpulat H, Daferera D, Tepe B, Polissiou M, Sokmen M, Sahin F. 2004. The in vitro antimicrobial and antioxidant activities of the essential oils and methanol extracts of endemic Thymus spathulifolius. Food Control, 15: 627-634. Song WJ, Hui CKM, Hull JH, Birring SS, Mcgarvey L, Mazzone SB, Chung, KF. 2021. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med, 9: 533-544. Süleyman K, Nesrin H, Veysel T, Ersin K, Hakan K. 2010. Chemical composition, antimicrobial and antioxidant activities of Hyssop (Hyssopus officinalis L.) essential oil. Notulae Botanicae Horti Agrobotanici Cluj-Napoca, 38: 33-39. Vahedian-Azimi A, Abbasifard M, RahimiBashar F, Guest PC, Majeed M, Mohammadi A, Banach M, Jamialahmadi T, Sahebkar A. 2022. Effectiveness of curcumin on outcomes of hospitalized COVID-19 patients: A systematic review of clinical trials. Nutrients, 14: 256-260. Vlase L, Benedec D, Hanganu D, Damian G, Csillag I, Sevastre B, Mot AC, SilaghiDumitrescu R, Tilea I. 2014. Evaluation of antioxidant and antimicrobial activities and phenolic profile for Hyssopus officinalis, ocimum basilicum and teucrium chamaedrys. Molecules, 19: 5490-5507. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. 2020. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA, 324: 782- 793. Yang Y, Islam MS, Wang J, Li Y, Chen X. 2020. Traditional chinese medicine in the treatment of patients infected with 2019- new coronavirus (SARS-CoV-2): a review and perspective. Int J Biol Sci, 16: 1708- 1717. Zahedipour F, Hosseini SA, Sathyapalan T, Majeed M, Jamialahmadi T, Al-Rasadi K, Banach M, Sahebkar A. 2020. Potential effects of curcumin in the treatment of COVID-19 infection. Phytother Res, 34: 2911-2920 | ||
|
آمار تعداد مشاهده مقاله: 13,107 تعداد دریافت فایل اصل مقاله: 4,740 |
||